In a recent @thrombosis-update.bsky.social article, the authors show that the Pathfast D-dimer assay is a rapid POC test for determination of D-dimer with good analytical performance. Read more here: sciencedirect.com/science/arti... @lucynortcd.bsky.social #TruJournal

New treatments have greatly improved survival for #cancer patients but they also come with a risk of #thrombosis. In our new review in @jthjournal.bsky.social we explain why. doi.org/10.1016/j.jt... @wardm6tcd.bsky.social @isth.org.

Our recent publication in British Journal of Cancer www.nature.com/articles/s41...

Congratulations Mark, fantastic work. Delighted to have been involved.

And, if anyone was wondering about the "science leaving Twitter for Bluesky" trend... the first 24h of this paper on altmetric:

"I want to read research that feels written for me." That line appeared in our workshop zines and stayed with us. Open access doesn’t automatically mean open understanding. Who do you write for? And who might feel left out? #openresearch #publicengagement

Study sheds light on how reams of fake scientific papers are getting into literature New study shows the ways that networks of researchers, editors and journals are cooperating to publish large numbers of fraudulent papers. @niamhordner.bsky.social writes @latimes.com www.latimes.com/science/stor...

🔔Reminder for @ISTH.org on-demand registrants: If you purchased on-demand access for the #ISTH2025 Congress, your access ends August 1! Make sure to log in and catch up on the sessions that matter most to you before time runs out: bit.ly/44Ub0FG

Only 5 days left to apply for this position, don't miss out!! If you are a Postdoc and looking for a job don't forget to check out this opportunity @UniversityLeeds below. Deadline for application is the 25th of July. Start date is the 1st of September.

A major KI initiative to recruit new assistant professors with outstanding proposals in all areas of medicine, biomedicine and public health. We offer an amazing research environment, great colleagues and generous startup packages. Check it out and get working on your applications! (repost please!)

State-of-the-Art talk bij de Luuk Scheres Despite hormone use being the most prevalent and important risk factor for #VTE in women <50, there is huge underrepresentation of risk models and funding. Food for thought and action 💪🏼 #ISTH2025

University of Galway is inviting the public to contribute to a new initiative aimed at exploring important health-related questions and helping shape the future of health research.🩺 Learn more and have your say: www.thepeoplesreview.ie @thepeoplesreview.ie

Safe #PE treatment for #cancer patients? Ultrasound-guided thrombolysis #CDT shows promise! New study in @thrombosis-update.bsky.social found similar low bleeding rates in cancer & non-cancer patients. Read more here: www.sciencedirect.com/science/arti... @lucynortcd.bsky.social #TruJournal

If you are still unsure whether to ask for your data to be deleted by 23andMe and any retained samples destroyed, have a read of this article in the New England Journal of Medicine @nejm.org.

Academic folks, here's proof that Bluesky is a great place to post citations. I am also noticing much better traction in general (I post for an academic group; despite a larger following on X there's much more interaction here).

New publication from our group in @naturecomms.bsky.social led by Gemma Leon @rcsi.bsky.social Thanks to our collaborators at @tcddublin.bsky.social, CHI Crumlin, and to @researchireland.bsky.social and Children’s Health Ireland for funding. Open access link: rdcu.be/d93ds

We’re Hiring! Cancer Trials Cork at CUH/UCC Cancer Centre seeks a proactive Operations Lead to manage operations, drive compliance & help patients regionally access cutting-edge treatments through clinical trials. Learn more: tinyurl.com/mubbxh5f 🕒 Apply before Friday 31st January 2025

Highly recommended opportunities! Great teams #hemesky

Great start to 2025 with the publication of our work lead by @lucynortcd.bsky.social! Here we report that chemotherapy alters the anticoagulant protein Thrombomodulin and FVIIIc in patients with gynaecological cancers, and tumour tissue FV being decreased in those who had a VTE shorturl.at/nj8eV

When 14 journals choose to publish the same article simultaneously, you know the topic is important. This is about predatory journals, which are out to catch the inexperienced authors. If you are thinking of submitting a paper following an invitation, read this first. #publishing

Is #cancer associated #thrombosis caused predominantly by the tumour or treatment. #chemotherapy has unique effects on the activated protein C pathway which may be important in VTE occuring during chemotherapy doi.org/10.1016/j.th....

Resignation of the Journal of Human Evolution Editorial Board: We are saddened to announce the resignations of The Joint Editors-in-Chief, all Emeritus Editors retired or active in the field, and all but one Associate Editor. Press release below.

Just because a paper is highly cited, it does not mean it is any good. The hydroxychloroquine paper as treatment of COVID-19 by Didier Raoult made international news, let to 1000s of patients taking an ineffective drug and was cited 3600 times. Retraction story in Nature journal tinyurl.com/ufjahnyd

Share your work on Blue Sky so you can get that stunning blue on your @altmetric.com ring

Here is the editorial commentary by @lucynortcd.bsky.social and Dr. Papadakis on the article by Mateo et al. in @thrombosis-update.bsky.social in which ther authors presented the data from the TESEO registry. Read more here: www.sciencedirect.com/science/arti...

Inspired by exciting #thrombosis and #hemostasis content you may have seen at @ash-hematology.bsky.social #ASH24? It gets even better at @isth-official.bsky.social #ISTH2025! Get ready and don’t miss to submit your abstracts by January 15! #HemeSky

Tissue factor (TF aka F3) is the main initiator of blood coagulation. In this new @thrombosis-update.bsky.social study, the authors determined the molecular epidemiology and the importance of #F3 variants for incident #VTE Read more: www.sciencedirect.com/science/arti... @lucynortcd.bsky.social

The hallmarks of cancer immune evasion

1/23 Big news for the #ObenaufLab! So excited to finally share our new study providing another puzzle piece, why immunotherapy fails in many tumors, now out in @Nature 🧵👇 www.nature.com/articles/s41...

Get ready to submit your research to the ISTH 2025 Congress in DC! Abstract submission site opens this Friday, November 29th. Submit your work for presentation to an intl audience & connect w/ others from around the 🌎: www.isth2025.org/abstracts 🩸 #hemesky #hemostasis #thrombosis

That’s helpful, thank you! ☺️ I used Path Outlines’ criteria but I recall from my own elective experiences the emphasis on Annexin A1.

Innovation shouldn't come at the expense of patient-centered care! Great article about prioritizing what matters to patients (QOL/OS/⬇️ burdens). It underscores palliative care being viewed as essential, not ancillary. We must rethink how we define progress in #oncology #pallonc #LCSM bit.ly/3OJQuQB

The migration of MedTwitter, along with a large cohort of science journalists, to BlueSky is striking in its scale and rapidity. In a short time, this shift has effectively transformed BlueSky into the essential hub for breaking medical news and vibrant scientific discourse.

As reviewer I "fell" for a paper written by AI, are there any new resources to train ourselves better? It contained many references but couldn't find fake ones #hemesky #medsky @marycushmanmd.bsky.social @profmakris.bsky.social

@thrombosis-update.bsky.social Thrombosis Update now on BlueSky.

Looking for figures for your illustrations? Don't have the budget for Biorender? Then be sure to check this out. A fantastic free resource from the NIH. https://bioart.niaid.nih.gov

Free resource, great for #SciComm ⬇️

Adding some blue skys from an Irish winter sunset for my first post